Who owns Seres Therapeutics Inc?
- Ticker: MCRB
- CUSIP Number: 81750r201
Tip: Access positions for across all investors
Analyze quarterly positions in Seres Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seres Therapeutics stock
Who bought or sold Seres Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Flagship Ventures Management | 1.2M | $17M | 0% | Dec 2025 |
|
| Susquehanna International | 333k | $5.0M | -15% | Dec 2025 |
|
| Vanguard Group | 324k | $4.8M | 4% | Dec 2025 |
|
| Marshall Wace | 120k | $1.8M | -4% | Dec 2025 |
|
| BlackRock | 104k | $1.5M | 2% | Dec 2025 |
|
| Vontobel Holding | 103k | $1.5M | 5% | Dec 2025 |
|
| Geode Capital Management | 86k | $1.3M | 1% | Dec 2025 |
|
| Citadel Advisors | 85k | $1.6M | 695% | Sep 2025 |
|
| Caption Management | 75k | $1.1M | 0% | Dec 2025 |
|
| 683 Capital Management | 52k | $778k | 100% | Dec 2025 |
|
| State Street Corporation | 34k | $504k | 14% | Dec 2025 |
|
| Lion Point Capital | 32k | $470k | 16% | Dec 2025 |
|
| Charles Schwab Investment Management | 31k | $467k | 0% | Dec 2025 |
|
| Jane Street | 30k | $445k | -56% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 29k | $433k | 1% | Dec 2025 |
|
| American Century Companies | 16k | $242k | 100% | Dec 2025 |
|
| Northern Trust | 15k | $220k | 22% | Dec 2025 |
|
| OMERS Administration Corporation | 14k | $214k | 100% | Dec 2025 |
|
| Invesco | 14k | $214k | 38% | Dec 2025 |
|
| Goldman Sachs Group | 14k | $213k | 100% | Dec 2025 |
|
| ExodusPoint Capital Management | 13k | $190k | 100% | Dec 2025 |
|
| Barclays | 7.4k | $111k | 428% | Dec 2025 |
|
| UBS Group | 4.2k | $63k | -67% | Dec 2025 |
|
| SBI Securities | 3.5k | $52k | 0% | Dec 2025 |
|
| FMR | 1.9k | $36k | -99% | Sep 2025 |
|
| Rachor Investment Advisory Services | 1.5k | $22k | 100% | Dec 2025 |
|
| Simplex Trading | 1.2k | $18k | -56% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 773.00 | $12k | 265% | Dec 2025 |
|
| Royal Bank of Canada | 296.00 | $5.8k | -96% | Sep 2025 |
|
| Wells Fargo & Company | 260.00 | $3.9k | 2500% | Dec 2025 |
|
| UMA Financial Services | 142.00 | $2.1k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 65.00 | $1.3k | 100% | Sep 2025 |
|
| Sound Income Strategies | 8.00 | $128.000000 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 8.00 | $119.000000 | 0% | Dec 2025 |
|
| Hanson McClain Advisors | 4.00 | $60.000000 | 100% | Dec 2025 |
|
| SRS Capital Advisors | 2.00 | $30.000000 | 0% | Dec 2025 |
|
Who sold out of Seres Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hudson Bay Capital Management | Sep 2025 | 125k | $2.4M |
| J. Goldman & Co | Sep 2025 | 89k | $1.7M |
| Centiva Capital | Sep 2025 | 25k | $481k |
| Wolverine Trading | Jun 2025 | 16k | $143k |
| Bridgeway Capital Management | Jun 2025 | 13k | $139k |
| Belvedere Trading | Sep 2025 | 12k | $235k |
| Us Bancorp | Sep 2025 | 12.00 | $231.000000 |
| Federation des caisses Desjardins du Quebec | Sep 2025 | 3.00 | $57.999900 |